NCT03047265View on ClinicalTrials.gov

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

February 4, 2017

Primary Completion Date

December 1, 2025

Study Completion Date

June 1, 2027

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

Paclitaxel

Paclitaxel 135mg / m2 D1, DDP 20mg / m2 D1-4, D1,D29 of RT, a total of 2 courses.

DRUG

Cisplatin

Cisplatin 100mg / m2 , D1,D22,D43 of RT, a total of 3 courses.

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER